Anhui Wanbang Pharmaceutical Technology Co.,Ltd. (SHE:301520)

SHE:301520 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Cash & Equivalents	214.34	150.3	179.29	253.5	186.35	161.55
Trading Asset Securities	853.84	1,001	1,023	902.81	-	-
Cash & Short-Term Investments	1,068	1,151	1,203	1,156	186.35	161.55
Cash Growth	-9.29%	-4.30%	4.02%	520.52%	15.35%	34.61%
Accounts Receivable	245.67	191.52	176.48	135.09	92.68	57.88
Other Receivables	3.12	2.07	3.99	3.24	-	-
Receivables	248.79	193.59	180.47	138.33	92.68	57.88
Inventory	1.42	0.87	1.96	0.67	0.44	0.18
Other Current Assets	18.51	14.68	17.54	66.88	6.75	6.36
Total Current Assets	1,337	1,360	1,403	1,362	286.22	225.97
Property, Plant & Equipment	205.89	200.64	176.43	150.01	97.28	42.15
Long-Term Investments	30.16	24	3	-	-	-
Other Intangible Assets	32.41	9.92	11.57	12	10.09	9.48
Long-Term Deferred Tax Assets	4.49	0.03	-	0.11	1.35	1
Long-Term Deferred Charges	0.31	0.85	2.75	9.58	5.39	3.16
Other Long-Term Assets	6.92	6.94	7.32	10.7	4.28	1.88
Total Assets	1,819	1,603	1,604	1,545	404.6	283.63

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Accounts Payable	50.12	33.42	37.83	27.02	7.86	4.75
Accrued Expenses	14.16	7.18	13.95	15.59	15.95	11.68
Short-Term Debt	39.53	1.6	1.6	1	-	-
Current Portion of Leases	1.13	-	-	-	0.03	0.12
Current Income Taxes Payable	0.35	0.06	0.27	0.31	1.67	3.62
Current Unearned Revenue	57.3	19.08	19.7	20.65	17.64	16.54
Other Current Liabilities	105.15	4.09	1.36	2.36	22.1	7.57
Total Current Liabilities	267.74	65.44	74.72	66.94	65.24	44.26
Long-Term Leases	0.9	-	-	-	-	0.03
Long-Term Unearned Revenue	9	9.9	7.41	6.55	2.94	2.95
Long-Term Deferred Tax Liabilities	6.96	6.79	8.31	7.1	4.8	3.51
Other Long-Term Liabilities	5	5	-	-	-	-
Total Liabilities	289.61	87.13	90.44	80.58	72.98	50.75

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Common Stock	93.17	66.67	66.67	66.67	50	50
Additional Paid-In Capital	1,013	1,039	1,037	1,037	29.79	29.79
Retained Earnings	405.62	425.35	412.12	359.92	251.83	153.1
Treasury Stock	-15.23	-15.23	-2.84	-	-	-
Total Common Equity	1,497	1,515	1,513	1,464	331.62	232.88
Minority Interest	32.56	-	-	-	-	-
Shareholders' Equity	1,529	1,515	1,513	1,464	331.62	232.88
Total Liabilities & Equity	1,819	1,603	1,604	1,545	404.6	283.63

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Total Debt	41.56	1.6	1.6	1	0.03	0.15
Net Cash (Debt)	1,027	1,149	1,201	1,155	186.32	161.41
Net Cash Growth	-12.70%	-4.31%	3.97%	520.08%	15.43%	34.49%
Net Cash Per Share	11.18	12.40	12.84	15.27	2.66	2.31
Filing Date Shares Outstanding	92.77	92.77	93.33	93.33	70	69.89
Total Common Shares Outstanding	92.77	92.77	93.33	93.33	70	69.89
Working Capital	1,069	1,295	1,328	1,295	220.97	181.71
Book Value Per Share	16.13	16.34	16.21	15.69	4.74	3.33
Tangible Book Value	1,263	1,505	1,502	1,452	321.52	223.4
Tangible Book Value Per Share	13.61	16.23	16.09	15.56	4.59	3.20
Buildings	94.1	94.1	94.1	90.51	8.95	8.95
Machinery	123.83	121.49	117.62	83.24	49.03	36.97
Construction In Progress	45.76	36.97	1.67	-	56.93	9.16

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 10, 2026

Data Sources Report a data error